Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Medpace unveils new clinical pharmacology unit in Ohio to support clinical research studies

Medpace : 19 December, 2007  (New Product)
Medpace has opened the Medpace Clinical Pharmacology Unit (Medpace CPU), which is a 50-bed clinical pharmacology unit in Cincinnati, Ohio, USA.
Medpace CPU is a state-of-the-art Phase I, IIa facility, focusing on confined/controlled pharmacokinetic/pharmacodynamic studies utilising human volunteers, with first-in-man capability.

The Medpace CPU is led by Jean Siebenaler, MD, who has extensive experience in clinical practice and CRO project management. The Medpace CPU will be managed by a team of highly trained, clinical research professionals, who are experts in the design, implementation, and analysis of Phase I and IIa studies.

Jim Wei, MD, PhD, will be responsible for reviewing the early Phase studies of sponsors' products, recommending studies, and assisting with Phase I/Phase IIa study designs. Dr Wei comes to Medpace from the FDA where he served as a senior reviewer in the Office of Clinical Pharmacology for almost 10 years where he was heavily involved in reviewing NDAs and INDs for the Divisions of Metabolism and Endocrinology Products.

Aligned with the Medpace approach of providing therapeutically focused clinical development services, the Medpace CPU will focus on studies in defined metabolic patient populations. The company's dedicated subject recruitment division, together with a strategic partnership with the renowned Metabolic and Atherosclerosis Research Center (MARC) led by Dr Evan Stein, will facilitate efficient recruitment of populations which include: diabetics (Types I and II), patients with metabolic syndromes and cardiovascular diseases.

The secure, state-of-the-art, 24-hour, 7-day a week facility, features a thirteen bed intensive care/observation unit. The Medpace CPU is located across the street from the Medpace Reference Laboratories, a full service central lab which features therapeutically specialised testing.

The site will have a full 12-Lead Mortara Telemetry system with wireless transmission to a centralised monitoring station which can monitor and record up to thirty-two patients simultaneously which allows for thorough QTc studies. The site also has the capacity for IV infusions, Holter monitoring, and pulmonary function testing.

Amenities for the study participants will include single beds, large flat screen TVs, video games, DVD players, desktop computers, wireless internet access, an enclosed outdoor courtyard, full-service catering, and a warming kitchen for in-house meal distribution.

The Medpace CPU is unprecedented in the region for its size and state-of- the-art equipment. The unit’s presence continues to enhance the area's growing healthcare reputation and a commitment to pharmaceutical research.

'We are pleased to offer this state-of-the-art, highly specialised Phase I and IIa facility for our clients,' said August Troendle, MD, Medpace chief executive officer. 'We believe our therapeutic expertise in cardiovascular, oncology, and metabolic clinical trials will be a unique offering in a market place that has a high demand for Phase I and II studies but rarely specialises in a few areas of focus.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo